Golden Eye (International) Limited v Telefónica UK Limited & Anor

A Norwich Pharmacal disclosure order may be proportionate where copyright owners show arguable infringement, a genuine intention to seek redress, and the necessity of disclosure, provided the order protects innocent and vulnerable subscribers. Copyright enforcement does not automatically outweigh privacy and data-protection rights. The court must apply an intense, case-specific balancing exercise between the competing rights.

Where copyright owners use a lawful commercial arrangement under which another entity controls enforcement and shares recoveries, that arrangement does not by itself justify refusing relief. The court must identify an additional impact on intended defendants beyond the risks already addressed by safeguards in the order and letter of claim. If the arrangement is not champertous or a speculative invoicing scheme, disapproval of revenue-sharing alone is insufficient.

The claimants, owners or exclusive licensees of copyrights in films, sought Norwich Pharmacal orders requiring Telefónica UK Ltd, trading as O2, to disclose the names and addresses of customers whose IP addresses had been associated with alleged BitTorrent infringement.

The High Court, in [2012] EWHC 723 (Ch), found arguable infringement and held that Golden Eye and Ben Dover Productions had a genuine intention to seek redress. It approved disclosure for those claimants subject to safeguards governing the order and proposed letters of claim, but refused relief to the Other Claimants. Their agreements authorised Golden Eye to control enforcement and receive a substantial share of recoveries. The High Court considered that making an order for them would improperly endorse that arrangement.

The Other Claimants appealed. The central issue was whether the revenue-sharing and litigation-control arrangements justified a different proportionality assessment from that reached for Golden Eye and Ben Dover Productions.

1. Appeal allowed. The High Court’s refusal of Norwich Pharmacal relief to the Other Claimants was set aside.
2. The proportionality exercise, required by Directive 2004/48/EC and the relevant Convention and Charter rights, required an intense focus on the comparative importance of the specific rights claimed. Neither the copyright owners’ property rights nor the subscribers’ privacy and data-protection rights had automatic precedence. The court had to consider the justification for interfering with or restricting each right and apply the ultimate balancing test to each.
3. The vulnerability of subscribers, their possible inability to obtain specialist legal advice, the embarrassment associated with allegations of unlawful pornography downloading, and the risk that innocent subscribers would pay rather than defend themselves were relevant to every claimant. Those matters were not an additional reason to refuse relief to the Other Claimants unless their arrangements created a further impact on intended defendants.
4. The High Court had found that the arrangements were not champertous, were not a speculative invoicing scheme, and did not undermine the court’s ability to control the disclosure process or subsequent claims. Its safeguards corrected misleading aspects of the proposed order and letter of claim, including the impression that infringement had already been established and the unjustified threat to restrict internet access. The proposed £700 payment could not be demanded as an arbitrary figure; any settlement sum had to be individually negotiated after appropriate information had been obtained.
5. The High Court’s additional reasoning—that relief would sanction the sale of subscribers’ privacy and data-protection rights to the highest bidder—was unsupported. The court was not sanctioning a sale. Golden Eye would be restricted to using disclosed information to enforce the Other Claimants’ intellectual-property rights.
6. With the safeguards in place, the balance favoured disclosure for the Other Claimants just as it did for Golden Eye and Ben Dover Productions. Relief was therefore to be granted on the amended terms.

• Court of Appeal (Civil Division) — [2012] EWCA Civ 1740: appeal by the Other Claimants allowed. The High Court’s refusal of Norwich Pharmacal relief was overturned.
• High Court of Justice, Chancery Division — [2012] EWHC 723 (Ch): disclosure orders granted for Golden Eye and Ben Dover Productions, subject to safeguards, but refused for the Other Claimants.